Ondansetron Tablet, Orally Disintegrating
Product Images NDC 62135-878

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 62135-878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ondansetron Od Tablets 4mg Label)

Ondansetron Orally Disintegrating Tablets, USP 4 mg tablet packaging label. The label indicates a quantity of 30 tablets, Rx only, manufactured by Chartwell RX, LLC. Storage and usage instructions and barcodes are also visible, including a 'No Varnish' note on the right side.*

FDA Label Image

Image Description (Ondansetron Od Tablets 8mg Label)

Packaging label for Ondansetron 8 mg Orally Disintegrating Tablets, USP by Chartwell RX, LLC. The label indicates a 30-tablet supply and specifies storage conditions, dosing information, and a precaution against removing tablets from the bottle prematurely. The label includes the NDC 62135-122-30 and a barcode.*

FDA Label Image

Image Description (Ondansetron Od Tablets Structure)

Chemical structure diagram of ondansetron, showing its molecular framework with labeled atoms and bonds as related to its active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.